Evaluating the healing outcomes of Mg OSTEOCRETE for bone defects

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Mg OSTEOCRETE, a synthetic bone substitute used to fill bone defects resulting from tumor excision, trauma, or loosening of orthopedic hardware. The study aims to assess the healing time and efficacy of Mg OSTEOCRETE through clinical evaluations and patient-reported outcomes. By comparing these outcomes, the research seeks to provide insights into the effectiveness of this alternative to traditional bone grafting methods. Participants will be monitored post-treatment to gather comprehensive data on their recovery process.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age and older on the day of surgery
* has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
* Mg OSTEOCRETE is indicated for one of the following reasons:

  1. as a bone void filler following bone tumor resection, or;
  2. as an augment for defects causing aseptic loosening of orthopaedic implants, or;
  3. to help substitute bone for trauma-related conditions

Exclusion Criteria:

* any contraindication as per Instructions for Use for Mg OSTEOCRETE

Where it's running

• Massachusetts General Hospital
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Santiago A Lozano-Calderon, MD, PhD — Massachusetts General Hospital
• Study coordinator: Shreya Halur, BS
• Email: shalur@mgh.harvard.edu
• Phone: 617-726-4932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating the AtMoves Knee System for diagnosing knee prosthesis loosening

  This study is testing if the AtMoves Knee System can help doctors better diagnose knee prosthesis loosening in patients who have had knee replacement surgery.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Nijmegen, Gelderland and 6 other locations · NCT06839807

• Metabolomic biomarkers for myotonic dystrophy

  This study tests whether urine and blood tests, along with muscle function tests, can detect and measure myotonic dystrophy activity and severity without relying on muscle biopsies.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07912983

• Two group-based, telehealth caregiver programs to reduce stress in dementia caregivers

  This trial tests whether Caring Together or Savvy Caregiver, delivered by telehealth, best reduces caregiver stress for people caring for someone with memory loss.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07868588

• Heart Rate Variability Biofeedback for Anxiety in Autistic Youth

  This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.

  Recruiting Phase 2 Massachusetts General Hospital · Lexington, Massachusetts · NCT07812233

• Brillouin hydration mapping to study cornea health

  Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07780890

• Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa

  This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07772167

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.